Biogen (NASDAQ: BIIB) announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development.Dr. Ehlers will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE